Becker's Healthcare April 5, 2023
Andrew Cass

A pair of Senators have introduced a bill aimed at limiting the alleged abusive pricing practices by pharmacy benefit managers, including the spread pricing technique.

The bill — dubbed the Drug Price Transparency in Medicaid Act of 2023 — would require Medicaid payments to PBMs to be passed directly to pharmacies, excluding administrative fees, according to an April 4 news release from Kansas Sen. Roger Marshall, MD. Dr. Marshall is sponsoring the bill along...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
Related Articles:
FTC pauses PBM litigation in win for Caremark, Express Scripts, Optum Rx
Pharma Dodges The Tariff Bullet — But For How Long?
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Q&A: How can drug repurposing lower drug costs and improve care?

Share This Article